RNS Number : 1828Z
Chemring Group PLC
05 August 2024
 

5 August 2024

 

Chemring Group PLC

 

Grant of options

 

 

Chemring Group PLC ("Chemring" or the "Company") announces that it has today granted, pursuant to The Chemring Group 2018 UK Sharesave Plan, options over 5,983 1p ordinary shares in the capital of the Company to James Mortensen, a director of the Company. The options will be exercisable in three years time at an exercise price of 310p per share.

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

 James Mortensen

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director/PDMR

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Chemring Group PLC

b)

 

LEI

 

 

213800U9A54VQJ5P2J41

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Options over 1p ordinary shares

 

 

 

GB00B45C9X44

b)

 

Nature of the transaction

 

 

Grant of options under The Chemring Group 2018 UK Sharesave Plan

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

310p

 

5,983

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

5 August 2024

f)

 

Place of the transaction

 

 

Outside a trading venue

 

 

For further information:

 

Chemring Group PLC


Sarah Ellard

Group Legal Director

+44 (0)1794 463420

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFIFIATFIEIIS